97 related articles for article (PubMed ID: 30292924)
1. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.
Rhee CK; van Boven JFM; Yau Ming SW; Park HY; Kim DK; Park HS; Ling JZJ; Yoo KH; Price DB
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):934-942. PubMed ID: 30292924
[TBL] [Abstract][Full Text] [Related]
2. Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
Muraki M; Gose K; Hanada S; Sawaguchi H; Tohda Y
Drug Deliv; 2017 Nov; 24(1):1395-1400. PubMed ID: 28929816
[TBL] [Abstract][Full Text] [Related]
3. Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence.
Park JH; Kim Y; Choi S; Jang EJ; Kim J; Lee CH; Yim JJ; Yoon HI; Kim DK
Sci Rep; 2019 Aug; 9(1):12004. PubMed ID: 31427602
[TBL] [Abstract][Full Text] [Related]
4. Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study.
Zheng J; Zhang J; Fu X; Lin C; Zhang X; Mei X; Corradi M; Cappellini G; Calabro E; Zhu C; Topole E
J Asthma; 2024 Apr; 61(4):360-367. PubMed ID: 37878325
[TBL] [Abstract][Full Text] [Related]
5. Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
Duh MS; Roberts MH; Rothnie KJ; Cheng WY; Thompson-Leduc P; Zhang S; Czira A; Slade D; Greatsinger A; Zhang A; Mapel D
Respir Med; 2024 May; 226():107629. PubMed ID: 38593885
[TBL] [Abstract][Full Text] [Related]
6. How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze.
van Aalderen WM; Garcia-Marcos L; Gappa M; Lenney W; Pedersen S; Dekhuijzen R; Price D
NPJ Prim Care Respir Med; 2015 Jan; 25():14088. PubMed ID: 25568979
[TBL] [Abstract][Full Text] [Related]
7. Real World Evidence asthma and COPD inhaled treatment therapy in Spain.
Muñoz X; Giner J; Sicras A; Re DL
Respir Care; 2024 Jun; ():. PubMed ID: 38906702
[No Abstract] [Full Text] [Related]
8. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.
Tan H; Sarawate C; Singer J; Elward K; Cohen RI; Smart BA; Busk MF; Lustig J; O'Brien JD; Schatz M
Mayo Clin Proc; 2009 Aug; 84(8):675-84. PubMed ID: 19648384
[TBL] [Abstract][Full Text] [Related]
9. Local variation in low carbon footprint inhalers in pre-COVID pandemic primary care prescribing guidelines for adult asthma in England and its potential impact.
Twigg AJ; Wilkinson A; Smith JN
Br J Clin Pharmacol; 2022 Dec; 88(12):5083-5092. PubMed ID: 36002398
[TBL] [Abstract][Full Text] [Related]
10. Inhaler usability of a pressurized metered dose inhaler and a soft mist inhaler in patients with COPD: A simulated-use study.
Ding B; Siddiqui S; DePietro M; Petersson G; Martin UJ
Chron Respir Dis; 2019; 16():1479972318787914. PubMed ID: 30016880
[TBL] [Abstract][Full Text] [Related]
11. Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial.
Krings JG; Wojcik KM; Chen V; Sekhar TC; Harris K; Zulich A; Sumino K; Brownson R; Lenze E; Castro M
Trials; 2022 Dec; 23(1):975. PubMed ID: 36471430
[TBL] [Abstract][Full Text] [Related]
12. Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.
Darbà J; Ramírez G; Sicras A; García-Bujalance L; Torvinen S; Sánchez-de la Rosa R
Patient Prefer Adherence; 2016; 10():135-45. PubMed ID: 26929605
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review.
Klijn SL; Hiligsmann M; Evers SMAA; Román-Rodríguez M; van der Molen T; van Boven JFM
NPJ Prim Care Respir Med; 2017 Apr; 27(1):24. PubMed ID: 28408742
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial.
Ohbayashi H; Kudo S; Ariga M
Pulm Ther; 2018 Dec; 4(2):159-169. PubMed ID: 32026393
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.
Martin RJ; Price D; Roche N; Israel E; van Aalderen WM; Grigg J; Postma DS; Guilbert TW; Hillyer EV; Burden A; von Ziegenweidt J; Colice G
NPJ Prim Care Respir Med; 2014 Oct; 24():14081. PubMed ID: 25297072
[TBL] [Abstract][Full Text] [Related]
16. Influence of Adherence to Inhaled Corticosteroids and Inhaler Handling Errors on Asthma Control in a Japanese Population.
Koya T; Hasegawa T; Takasawa J; Yoshimine F; Sakagami T; Hayashi M; Suzuki E; Kikuchi T;
Intern Med; 2018 Dec; 57(23):3357-3363. PubMed ID: 30101909
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.
Westerik JA; Carter V; Chrystyn H; Burden A; Thompson SL; Ryan D; Gruffydd-Jones K; Haughney J; Roche N; Lavorini F; Papi A; Infantino A; Roman-Rodriguez M; Bosnic-Anticevich S; Lisspers K; Ställberg B; Henrichsen SH; van der Molen T; Hutton C; Price DB
J Asthma; 2016; 53(3):321-9. PubMed ID: 26810934
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
Roberts MH; Duh MS; Rothnie KJ; Zhang S; Czira A; Slade D; Cheng WY; Thompson-Leduc P; Greatsinger A; Zhang A; Mapel D
Respir Med; 2024 May; 226():107630. PubMed ID: 38593886
[TBL] [Abstract][Full Text] [Related]
19. Changes in disease burden and treatment reality in patients with severe asthma.
Nagase H; Oka H; Uchimura H; Arita Y; Hirai T; Makita N; Tashiro N; Matsunaga K
Respir Investig; 2024 May; 62(3):431-437. PubMed ID: 38492333
[TBL] [Abstract][Full Text] [Related]
20. Climate change in healthcare: Exploring the potential role of inhaler prescribing.
Starup-Hansen J; Dunne H; Sadler J; Jones A; Okorie M
Pharmacol Res Perspect; 2020 Dec; 8(6):e00675. PubMed ID: 33124196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
